The interaction between IL-6 in the TIME and cancer stem cell enrichment warrants further investigation as a potential therapeutic target in glioblastoma, as the relationship between IL-6 signaling and cancer stem cell growth has been established in other solid malignancies60 and is likely related to STAT361. Here, IL6 is linked to cancer.